TORONTO, Aug 13 (Reuters) - Drugmaker Biovail Corp which won a long and ugly proxy fight last week, reported a second-quarter loss on Wednesday, hurt by restructuring charges and legal and proxy contest costs.
TORONTO, Aug 13 (Reuters) - Drugmaker Biovail Corp which won a long and ugly proxy fight last week, reported a second-quarter loss on Wednesday, hurt by restructuring charges and legal and proxy contest costs.
